Szostak Nobel prize in medicine

Jack W. Szostak, a geneticist at Harvard Medical School, is one of three co-winners of the 2009 prize.

Jack Szostak

Professor of genetics Jack W. Szostak has won the Nobel Prize in Physiology or Medicine with Elizabeth H. Blackburn (University of California, San Francisco) and Carol W. Greider (Johns Hopkins School of Medicine). The three scientists were recognized for their work on how chromosomes are protected by telomeres and the enzyme telomerase. Szostak's home page at Harvard Medical School details his recent work on the synthesis of life on earth: "the related challenges of understanding the origin of life on the early earth, and constructing synthetic cellular life in the laboratory." His lab home page is here; he is also a Howard Hughes Medical Institute investigator, and  has a biographical page there, emphasizing his current work on the origins of life and the re-creation of the first steps in biological synthesis. Harvard's Origins of Life Initiative is described here; Szostak is one of the affiliated faculty members.

According to the Nobel press release, the trio have solved a critical part of a fundamental problem in biology: "how the chromosomes can be copied in a complete way during cell divisions and how they are protected against degradation. The Nobel Laureates have shown that the solution is to be found in the ends of the chromosomes--the telomeres--and in an enzyme that forms them – telomerase."


The explanation continues:

The long, thread-like DNA molecules that carry our genes are packed into chromosomes, the telomeres being the caps on their ends. Elizabeth Blackburn and Jack Szostak discovered that a unique DNA sequence in the telomeres protects the chromosomes from degradation. Carol Greider and Elizabeth Blackburn identified telomerase, the enzyme that makes telomere DNA. These discoveries explained how the ends of the chromosomes are protected by the telomeres and that they are built by telomerase.


If the telomeres are shortened, cells age. Conversely, if telomerase activity is high, telomere length is maintained, and cellular senescence is delayed. This is the case in cancer cells, which can be considered to have eternal life. Certain inherited diseases, in contrast, are characterized by a defective telomerase, resulting in damaged cells. The award of the Nobel Prize recognizes the discovery of a fundamental mechanism in the cell, a discovery that has stimulated the development of new therapeutic strategies.

 

Related topics

You might also like

Former ICC Prosecutor Discusses Iran, Ukraine, and Venezuela

At a Harvard event, Luis Moreno-Ocampo explains why war crimes are hard to define and prosecute. 

Harvard Weathers a Year of Turmoil

The federal government has launched unprecedented actions against the University. Here’s a guide.

Scoundrels, Then and Now

On con men, Mark Twain, and the powers of the Harvard name

Most popular

Harvard Discloses Top Administrator and Investment Manager Compensation

Investment pay drops—top six managers’ earnings total a little more than $25 million

Harvard Answers Government Admissions Lawsuit

In a separate case, the Trump administration outlines its argument for the federal funding freeze. 

At Harvard, Mitt Romney Warns Against ‘Authoritarian’ Presidential Power

The former senator touched on polarization, tech governance, and diplomacy during a conversation at the Institute of Politics.

Explore More From Current Issue

Brick archway with a sandy base, surrounded by wooden planks and boxes in a dim space.

How the American Revolution Freed a Future Abolitionist

Darby Vassall, an enslaved child freed after the Battle of Bunker Hill, dedicated his life to fighting for liberty.

Bronze statues of three historical figures under a stylized tree in a softly lit space.

The Costly Choice Native Americans Faced

How the Revolution reshaped indigenous New England

A dancer in a black leotard poses gracefully in a bright studio, with mirrors reflecting her movement.

A New ‘Black Swan’ Musical Cranks Up the Tension

The creative team of the A.R.T.’s new show dish on adapting Darren Aronofsky’s thriller classic from screen to stage.